Vierling JM - Search Results

1

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.

Bourlière M, Gordon SC, Flamm SL, Cooper CL, Ramji A, Tong M, Ravendhran N, Vierling JM, Tran TT, Pianko S, Bansal MB, de Lédinghen V, Hyland RH, Stamm LM, Dvory-Sobol H, Svarovskaia E, Zhang J, Huang KC, Subramanian GM, Brainard DM, McHutchison JG, Verna EC, Buggisch P, Landis CS, Younes ZH, Curry MP, Strasser SI, Schiff ER, Reddy KR, Manns MP, Kowdley KV, Zeuzem S; POLARIS-1 and POLARIS-4 Investigators. Bourlière M, et al. Among authors: vierling jm. N Engl J Med. 2017 Jun 1;376(22):2134-2146. doi: 10.1056/NEJMoa1613512. N Engl J Med. 2017. PMID: 28564569 Free article. Clinical Trial.

2

Detection of hepatitis C virus with RNA polymerase chain reaction in fulminant hepatic failure.

Villamil FG, Hu KQ, Yu CH, Lee CH, Rojter SE, Podesta LG, Makowka L, Geller SA, Vierling JM. Villamil FG, et al. Among authors: vierling jm. Hepatology. 1995 Nov;22(5):1379-86. Hepatology. 1995. PMID: 7590651

3

Acute hepatitis associated with the Chinese herbal product jin bu huan.

Woolf GM, Petrovic LM, Rojter SE, Wainwright S, Villamil FG, Katkov WN, Michieletti P, Wanless IR, Stermitz FR, Beck JJ, Vierling JM. Woolf GM, et al. Among authors: vierling jm. Ann Intern Med. 1994 Nov 15;121(10):729-35. doi: 10.7326/0003-4819-121-10-199411150-00001. Ann Intern Med. 1994. PMID: 7944049

4

Hepatitis C virus is not recoverable from liver tissue in cryptogenic cirrhosis: failure to identify hepatitis C virus-RNA using reverse transcription-mediated polymerase chain reaction.

Geller SA, Nichols WS, Rojter SE, Chan RC, Petrovic LM, Vierling JM, Makowka L. Geller SA, et al. Among authors: vierling jm. Hum Pathol. 1996 Nov;27(11):1161-5. doi: 10.1016/s0046-8177(96)90309-3. Hum Pathol. 1996. PMID: 8912825

5

Morbidity and mortality of recurrent hepatitis C infection after orthotopic liver transplantation.

Vierling JM, Villamil FG, Rojter SE, Camacho KB, Goldman DE. Vierling JM, et al. J Viral Hepat. 1997;4 Suppl 1:117-24. doi: 10.1111/j.1365-2893.1997.tb00172.x. J Viral Hepat. 1997. PMID: 9097290 Review.

6

Protracted cholestatic hepatitis after the use of prostata.

Hamid S, Rojter S, Vierling J. Hamid S, et al. Ann Intern Med. 1997 Jul 15;127(2):169-70. doi: 10.7326/0003-4819-127-2-199707150-00033. Ann Intern Med. 1997. PMID: 9230022 No abstract available.

7

Treatment of the postoperative alcoholic liver transplant recipient with other addictions.

Coffman KL, Hoffman A, Sher L, Rojter S, Vierling J, Makowka L. Coffman KL, et al. Liver Transpl Surg. 1997 May;3(3):322-7. doi: 10.1002/lt.500030320. Liver Transpl Surg. 1997. PMID: 9346758 Free article. No abstract available.

8

Posttransplantation: future therapies.

Peters MG, Shouval D, Bonham A, Vierling JM, Lok AS. Peters MG, et al. Among authors: vierling jm. Semin Liver Dis. 2000;20 Suppl 1:19-24. Semin Liver Dis. 2000. PMID: 10895440 Review.

9

Case studies of the hepatitis B patient: a panel discussion.

Vierling JM, Teperman LW, Lake JR, Perrillo RP, Peters M, Fried M, Schiff ER. Vierling JM, et al. Semin Liver Dis. 2000;20 Suppl 1:29-35. Semin Liver Dis. 2000. PMID: 10895442

10

Imatinib (Gleevec)-induced hepatotoxicity.

Ayoub WS, Geller SA, Tran T, Martin P, Vierling JM, Poordad FF. Ayoub WS, et al. Among authors: vierling jm. J Clin Gastroenterol. 2005 Jan;39(1):75-7. J Clin Gastroenterol. 2005. PMID: 15599217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page